An aggregation-specific enzyme-linked immunosorbent assay:: Detection of conformational differences between recombinant PrP protein dimers and PrPSc aggregates
An aggregation-specific enzyme-linked immunosorbent assay:: Detection of conformational differences between recombinant PrP protein dimers and PrPSc aggregates
复制标题
DOI:
10.1128/jvi.79.19.12355-12364.2005
复制
发表时间:
2005-10-01
影响因子:
5.4
通讯作者:
Sy, MS
中科院分区:
文献类型:
--
作者:
Pan, T;Chang, BG;Sy, MS
The conversion of the normal cellular prion protein, PrPC, into the protease-resistant, scrapie PrPSc aggregate is the cause of prion diseases. We developed a novel enzyme-linked immunosorbent assay (ELISA) that is specific for PrP aggregate by screening 30 anti-PrP monoclonal antibodies (MAbs) for their ability to react with recombinant mouse, ovine, bovine, or human PrP dimers. One MAb that reacts with all four recombinant PrP dimers also reacts with PrPSc aggregates in ME7-, 139A-, or 22L-infected mouse brains. The PrPSc aggregate is proteinase K resistant, has a mass of 2,000 kDa or more, and is present at a time when no protease-resistant PrP is detectable. This simple and sensitive assay provides the basis for the development of a diagnostic test for prion diseases in other species. Finally, the principle of the aggregate-specific ELISA we have developed may be applicable to other diseases caused by abnormal protein aggregation, such as Alzheimer's disease or Parkinson's disease.